Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKhann GM, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7(3): p:263–9.

Article  Google Scholar 

Gallardo G, Holtzman DM. Amyloid‑β and Tau at the Crossroads of Alzheimer’s Disease. Tau. Biology. 2019; 187–203.

Jellinger KA. Neuropathological assessment of the Alzheimer spectrum. J Neural Transm. 2020;127(9):1229–56.

Article  CAS  PubMed  Google Scholar 

Penke B, Bogár F, Fülöp L. β‑Amyloid and the pathomechanisms of Alzheimer’s disease: a comprehensive view. Molecules. 2017;22(10):1692.

Article  PubMed  PubMed Central  Google Scholar 

MacLeod R, et al. The role and therapeutic targeting of α‑, β‑and γ‑secretase in Alzheimer’s disease. Future Sci OA. 2015;1(3).

Garbuz D, Zatsepina O, Evgen’ev M. Beta amyloid, tau protein, and neuroinflammation: an attempt to integrate different hypotheses of Alzheimer’s disease pathogenesis. Mol Biol. 2021;55: p:670–82.

Article  Google Scholar 

Jellinger, K.A., A critical evaluation of current staging of α‑synuclein pathology in Lewy body disorders. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2009. 1792(7): p. 730–740.

Twohig D, Nielsen HM. α‑synuclein in the pathophysiology of Alzheimer’s disease. Mol Neurodegeneration. 2019;14(1):23.

Article  Google Scholar 

Chandra S, Sisodia SS, Vassar RJ. The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored. Mol Neurodegeneration. 2023;18(1):9.

Article  Google Scholar 

Berer K, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538–41.

Article  CAS  PubMed  Google Scholar 

Minter MR, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep. 2016;6(1):30028.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dodiya HB, et al. Gut microbiota—driven brain Aβ amyloidosis in mice requires microglia. J Exp Med. 2021;219(e20200895):1.

Google Scholar 

Honarpisheh P, et al. Dysregulated gut homeostasis observed prior to the accumulation of the brain amyloid‑β in Tg2576 mice. IJMS. 2020;21(5):1711.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong S‑R, et al. Functional roles of the microbiota-gut-brain axis in Alzheimer’s disease: Implications of gut microbiota-targeted therapy. Transl Neurosci. 2021;12(1):581–600.

Article  PubMed  PubMed Central  Google Scholar 

Cattaneo A, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49: p:60–8.

Article  Google Scholar 

Bello-Corral L, et al. Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer’s disease. Life Sci. 2023;p:122132.

Article  Google Scholar 

Serena C, et al. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 2018;12(7):1642–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung C‑C, et al. Gut microbiota in patients with Alzheimer’s disease spectrum: a systematic review and meta-analysis. Aging (albany Ny). 2022;14(1):477.

Article  PubMed  PubMed Central  Google Scholar 

Kaiko GE, Stappenbeck TS. Host—microbe interactions shaping the gastrointestinal environment. Trends Immunol. 2014;35(11):538–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cryan JF, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;.

Rutsch A, Kantsjö JB, Ronchi F. The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol. 2020;11: p:604179.

Article  Google Scholar 

Megur A, et al. The microbiota—gut—brain axis and Alzheimer’s disease: neuroinflammation is to blame? Nutrients. 2020;13(1):37.

Article  PubMed  PubMed Central  Google Scholar 

Qian X‑h, et al. Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota. Ageing Res Rev. 2021;68: p:101317.

Article  Google Scholar 

Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160(5):1486–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin CR, et al. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–48.

Article  PubMed  PubMed Central  Google Scholar 

Carco C, et al. Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis. Front Cell Infect Microbiol. 2020;10: p:468.

Article  Google Scholar 

Mayer EA. Gut feelings: the emerging biology of gut—brain communication. Nat Rev Neurosci. 2011;12(8):453–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–12.

Article  CAS  PubMed  Google Scholar 

Vuong HE, Hsiao EY. Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry. 2017;81(5):411–23.

Article  PubMed  Google Scholar 

Sochocka M, et al. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease—a critical review. Mol Neurobiol. 2019;56: p:1841–51.

Article  Google Scholar 

Jangi S, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7(1):12015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toh TS, et al. Gut microbiome in Parkinson’s disease: New insights from meta-analysis. Park Relat Disord. 2022;94: p:1–9.

Article  Google Scholar 

Goudman L, et al. Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis. Front Immunol. 2024;15: p:1342833.

Article  Google Scholar 

Rehfeld JF. Gastrointestinal hormones and their targets. Microbial endocrinology: The microbiota-gut-brain axis in health and disease. 2014. pp. 157–75.

Google Scholar 

Yano JM, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gershon MD. 5‑Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1): p:14–21.

Article  Google Scholar 

Rothhammer V, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557(7707):724–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Riordan KJ, et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546: p:111572.

Article  Google Scholar 

Conn AR, Fell DI, Steele RD. Characterization of alpha-keto acid transport across blood-brain barrier in rats. Am J Physiol Metab. 1983;245(3):E253–E60.

CAS  Google Scholar